Kimball Electronics 3Q 2026: Revenue $390.8M, EPS $0.11 — 10-Q Summary
Kimball Electronics reported 3Q 2026 revenue of $390.8M, up 7% YoY, but net income fell 73.8% to $2.64M due to higher expenses. Medical and Helvoet sales drove growth, while Indianapolis facility costs impacted margins. Open orders rose 16% to $690M.
How this was made
The 30-second read
Why it matters
The earnings miss may prompt short sellers and cause the stock to trade lower in after‑hours.
Market read
Primary earnings disclosure for a micro‑cap; relevant for traders focused on small‑cap earnings volatility.
What to watch
Strong medical demand and a 14% rise in medical sales may offset longer‑term concerns.
Background
Kimball Electronics filed its Q1 2027 10‑Q, reporting modest revenue growth but a sharp earnings decline.
Ticker impact
Q1 fiscal 2027 net sales rose 6.9% YoY to $390.8M, but net income fell 73.8% to $2.64M, EPS $0.11.
downward pressure as the market prices in weaker earnings and higher expenses.
Revenue growth was modest while net income collapsed, suggesting margin compression and a likely share price decline.
Market effects
Signals pressure on the broader electronics manufacturing sector as margins tighten.
Limited to U.S. small‑cap investors; no broad regional effect.
Low global relevance; impact confined to niche component suppliers.
Counterpoint
If the acquisition of Helvoet drives future growth, the stock could rebound despite the near‑term miss.
Key entities
- CompanyKimball Electronics, Inc.
U.S. electronics components manufacturer (ticker KE).
